Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Artif Cells Nanomed Biotechnol
2 BJU Int
1 BMC Urol
1 Cancer Res
1 Carcinogenesis
1 Cent Eur J Immunol
1 Clin Chim Acta
3 Clin Epigenetics
1 Clin Genitourin Cancer
1 Clin Transl Oncol
1 Curr Oncol Rep
1 Diabetol Int
1 Environ Toxicol
2 Eur Urol
6 Eur Urol Focus
2 Female Pelvic Med Reconstr Surg
2 Hinyokika Kiyo
1 Int Braz J Urol
1 Int J Mol Sci
1 Int J Oncol
1 Int J Vitam Nutr Res
1 Int Urol Nephrol
1 J Biol Chem
1 J Cell Biochem
1 J Clin Oncol
1 J Endourol
1 J Med Case Rep
1 J Natl Cancer Inst
2 Oncogene
2 Oncol Rep
1 Pathol Oncol Res
1 Photodiagnosis Photodyn Ther
1 PLoS One
1 Qual Life Res
1 Radiol Med
1 Rev Esp Patol
1 Scand J Urol
1 Vet Clin Pathol
1 Vet Comp Oncol
3 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Artif Cells Nanomed Biotechnol

  1. WU T, Duan X, Hu C, Wu C, et al
    Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells.
    Artif Cells Nanomed Biotechnol. 2019;47:512-523.
    PubMed     Text format     Abstract available

    BJU Int

  2. TARIQ A, Khan SR, Vela I, Williams ED, et al
    Assessment of bladder cancer patients and carers use of internet, social media and quality of available patient centric online resources: A systematic review.
    BJU Int. 2019 Feb 24. doi: 10.1111/bju.14720.
    PubMed     Text format     Abstract available

  3. KIJIMA T, Tanaka H, Koga F, Masuda H, et al
    Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.
    BJU Int. 2019 Feb 27. doi: 10.1111/bju.14736.
    PubMed     Text format     Abstract available

    BMC Urol

  4. TALAT Z, Onal B, Cetinel B, Demirdag C, et al
    The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy.
    BMC Urol. 2018;18:94.
    PubMed     Text format     Abstract available

    Cancer Res

  5. WANG Z, Cao D, Qi Z, Pang Y, et al
    Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer.
    Cancer Res. 2019 Feb 26. pii: 0008-5472.CAN-18-3842.
    PubMed     Text format     Abstract available


  6. AVGERIS M, Tsilimantou A, Levis PK, Rampias T, et al
    Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Carcinogenesis. 2019 Feb 27. pii: 5366409. doi: 10.1093.
    PubMed     Text format     Abstract available

    Cent Eur J Immunol

  7. POLETAJEW S, Fus L, Ilczuk T, Wojcieszak P, et al
    Expression of E-cadherin, beta-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.
    Cent Eur J Immunol. 2018;43:421-427.
    PubMed     Text format     Abstract available

    Clin Chim Acta

  8. FOGAZZI GB, Delanghe J
    Microscopic examination of urine sediment: Phase contrast versus bright field.
    Clin Chim Acta. 2018;487:168-173.
    PubMed     Text format     Abstract available

    Clin Epigenetics

  9. KALETSCH A, Pinkerneil M, Hoffmann MJ, Jaguva Vasudevan AA, et al
    Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Clin Epigenetics. 2018;10:100.
    PubMed     Text format     Abstract available

  10. SANFORD T, Meng MV, Railkar R, Agarwal PK, et al
    Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Clin Epigenetics. 2018;10:19.
    PubMed     Text format     Abstract available

  11. HOLSCHER AS, Schulz WA, Pinkerneil M, Niegisch G, et al
    Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
    Clin Epigenetics. 2018;10:1.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  12. BALAKRISHNAN AS, Washington SL 3rd, Meng MV, Porten SP, et al
    Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 19. pii: S1558-7673(19)30018.
    PubMed     Text format     Abstract available

    Clin Transl Oncol

  13. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2019 Feb 26. pii: 10.1007/s12094-019-02061.
    PubMed     Text format     Abstract available

    Curr Oncol Rep

  14. MATULAY JT, Narayan VM, Kamat AM
    Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
    Curr Oncol Rep. 2019;21:23.
    PubMed     Text format     Abstract available

    Diabetol Int

  15. MEHTALA J, Khanfir H, Bennett D, Ye Y, et al
    Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.
    Diabetol Int. 2018;10:24-36.
    PubMed     Text format     Abstract available

    Environ Toxicol

  16. CHIANG CH, Chung JG, Hsu FT
    Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-kappaB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Environ Toxicol. 2019 Feb 25. doi: 10.1002/tox.22734.
    PubMed     Text format     Abstract available

    Eur Urol

  17. PICHLER R, Heidegger I
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.11.055.
    Eur Urol. 2019 Feb 22. pii: S0302-2838(19)30159.
    PubMed     Text format    

    Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    Eur Urol. 2019 Feb 25. pii: S0302-2838(19)30163.
    PubMed     Text format    

    Eur Urol Focus

  19. VETTERLEIN MW, Seisen T, May M, Nuhn P, et al
    Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Eur Urol Focus. 2018;4:252-259.
    PubMed     Text format     Abstract available

  20. JOSHI M, Millis SZ, Arguello D, Holder SL, et al
    Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.
    Eur Urol Focus. 2018;4:94-97.
    PubMed     Text format     Abstract available

  21. MOSCHINI M, Morlacco A, Briganti A, Hu B, et al
    Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Eur Urol Focus. 2018;4:245-251.
    PubMed     Text format     Abstract available

  22. GURUNG PMS, Barnett AR, Wilson JS, Hudson J, et al
    Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
    Eur Urol Focus. 2019 Feb 22. pii: S2405-4569(19)30032.
    PubMed     Text format     Abstract available

  23. COLOMBO R, Hurle R, Moschini M, Freschi M, et al
    Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Eur Urol Focus. 2018;4:87-93.
    PubMed     Text format     Abstract available

  24. SATHIANATHEN NJ, Fan Y, Jarosek SL, Konety I, et al
    Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Eur Urol Focus. 2019 Feb 20. pii: S2405-4569(19)30027.
    PubMed     Text format     Abstract available

    Female Pelvic Med Reconstr Surg

  25. BRETSCHNEIDER CE, Share SM, Paraiso MFR
    Nephrogenic Adenoma in the Setting of Refractory Labial Agglutination in an Elderly Woman.
    Female Pelvic Med Reconstr Surg. 2018;24:e6-e8.
    PubMed     Text format     Abstract available

  26. JOHANSSON S, Walters R, Mayer K, Shippey S, et al
    Vaginal Myomectomy to Resolve Bladder Outlet Obstruction 50 Years After Hysterectomy.
    Female Pelvic Med Reconstr Surg. 2018;24:e26-e28.
    PubMed     Text format     Abstract available

    Hinyokika Kiyo

  27. UCHIDA M, Kawai K, Kurobe M, Ikeda A, et al
    [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
    Hinyokika Kiyo. 2018;64:55-61.
    PubMed     Text format     Abstract available

  28. HORI S, Mitsui Y, Suzuki K, Nakajima K, et al
    [Penile Metastasis from Invasive Bladder Carcinoma Diagnosed by Needle Biopsy : A Case Report and Literature Review].
    Hinyokika Kiyo. 2018;64:127-130.
    PubMed     Text format     Abstract available

    Int Braz J Urol

  29. JIN L, Wang M, Yang F, Niu Y, et al
    Surgical techniques for facilitating laparoscopic intracorporeal orthotopic neobladder: initial experience.
    Int Braz J Urol. 2018;44:1156-1165.
    PubMed     Text format     Abstract available

    Int J Mol Sci

  30. LIN JJ, Huang CC, Su YL, Luo HL, et al
    Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available

    Int J Oncol

  31. HUANG Z, Zhang M, Chen G, Wang W, et al
    Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4729.
    PubMed     Text format     Abstract available

    Int J Vitam Nutr Res

  32. LIN JH, Chen SJ, Liu H, Yan Y, et al
    Vitamin E consumption and the risk of bladder cancer.
    Int J Vitam Nutr Res. 2019 Feb 26:1-8. doi: 10.1024/0300-9831/a000553.
    PubMed     Text format     Abstract available

    Int Urol Nephrol

  33. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    PubMed     Text format     Abstract available

    J Biol Chem

  34. JIANG G, Huang C, Liao X, Li J, et al
    The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.
    J Biol Chem. 2019 Feb 28. pii: RA118.005621. doi: 10.1074/jbc.RA118.005621.
    PubMed     Text format     Abstract available

    J Cell Biochem

  35. HUANG SY, Chien CC, Hseu RS, Huang VYJ, et al
    Ganoderma microsporum immunomodulatory protein induces apoptosis and potentiates mitomycin C-induced apoptosis in urinary bladder urothelial carcinoma cells.
    J Cell Biochem. 2018;119:4592-4606.
    PubMed     Text format     Abstract available

    J Clin Oncol

  36. ZHANG S
    Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    J Clin Oncol. 2019 Feb 27:JCO1801864. doi: 10.1200/JCO.18.01864.
    PubMed     Text format    

    J Endourol

    Editorial Comment on: Isolated Red Patches Seen During Endoscopic Surveillance of Bladder Cancer: Incidence of Malignancy and When Should We Biopsy? by Nkwam et al.
    J Endourol. 2018;32:328.
    PubMed     Text format    

    J Med Case Rep

  38. AHSAINI M, Ouattar K, Azelmad H, Mellas S, et al
    A rare pure embryonal rhabdomyosarcoma of the urinary bladder in an adult successfully managed with neoadjuvant chemotherapy and surgery: a case report.
    J Med Case Rep. 2018;12:329.
    PubMed     Text format     Abstract available

    J Natl Cancer Inst

  39. SMITH AH, Marshall G, Roh T, Ferreccio C, et al
    Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction.
    J Natl Cancer Inst. 2018;110:241-249.
    PubMed     Text format     Abstract available


  40. LIU Q, Gheorghiu L, Drumm M, Clayman R, et al
    PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
    Oncogene. 2018;37:2793-2805.
    PubMed     Text format     Abstract available

  41. LIU JY, Zeng QH, Cao PG, Xie D, et al
    SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.
    Oncogene. 2018;37:3937-3952.
    PubMed     Text format     Abstract available

    Oncol Rep

  42. HO JN, Byun SS, Lee SE, Youn JI, et al
    Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatinresistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Oncol Rep. 2019 Feb 11. doi: 10.3892/or.2019.7005.
    PubMed     Text format     Abstract available

  43. ZHUO Z, Song Z, Ma Z, Zhang Y, et al
    Chlorophyllin e6mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells.
    Oncol Rep. 2019 Feb 14. doi: 10.3892/or.2019.7013.
    PubMed     Text format     Abstract available

    Pathol Oncol Res

  44. AFSHARPAD M, Nowroozi MR, Mobasheri MB, Ayati M, et al
    Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Pathol Oncol Res. 2019;25:191-199.
    PubMed     Text format     Abstract available

    Photodiagnosis Photodyn Ther

  45. DO NASCIMENTO ALVES SIPM, Lavalhegas Hallack M, Moreira Perez M, da Costa Aguiar Alves B, et al
    Application of the Z-scan technique for the detection of CFCDNA (cell-free circulating DNA) and urine DNA (uDNA) in patients with bladder cancer.
    Photodiagnosis Photodyn Ther. 2019 Feb 26. pii: S1572-1000(18)30338.
    PubMed     Text format    

    PLoS One

  46. SIMON M, Bosset PO, Rouanne M, Benhamou S, et al
    Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
    PLoS One. 2019;14:e0211721.
    PubMed     Text format     Abstract available

    Qual Life Res

  47. LI Y, Rapkin B, Atkinson TM, Schofield E, et al
    Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.
    Qual Life Res. 2019 Feb 23. pii: 10.1007/s11136-019-02132.
    PubMed     Text format     Abstract available

    Radiol Med

  48. FERSINO S, Arcangeli S, Jereczek-Fossa BA, D'Angelillo R, et al
    GUROPA survey: genito-urinary radiation oncology prescription attitudes.
    Radiol Med. 2018;123:879-884.
    PubMed     Text format     Abstract available

    Rev Esp Patol

  49. FERNANDEZ-ACENERO MJ, Perez Alonso P, Diaz Del Arco C
    Histiocytic sarcoma with bladder involvement: Case report and literature review.
    Rev Esp Patol. 2018;51:23-26.
    PubMed     Text format     Abstract available

    Scand J Urol

  50. TURKER P, Segersten U, Malmstrom PU, Hemdan T, et al
    Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
    Scand J Urol. 2019 Feb 26:1-6. doi: 10.1080/21681805.2019.1575467.
    PubMed     Text format     Abstract available

    Vet Clin Pathol

  51. FIELDER S, Breshears M
    What is your diagnosis? Bladder mass in a mare.
    Vet Clin Pathol. 2018;47:665-666.
    PubMed     Text format    

    Vet Comp Oncol

  52. SHIMIZU N, Hamaide A, Dourcy M, Noel S, et al
    Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours.
    Vet Comp Oncol. 2019;17:11-20.
    PubMed     Text format     Abstract available

    World J Urol

  53. DATOVO JCF, Neto WA, Mendonca GB, Andrade DL, et al
    Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02697.
    PubMed     Text format     Abstract available

  54. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02689.
    PubMed     Text format     Abstract available

  55. CHOI JB, Kim JH, Hong SH, Han KD, et al
    Association of body mass index with bladder cancer risk in men depends on abdominal obesity.
    World J Urol. 2019 Feb 26. pii: 10.1007/s00345-019-02690.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.